Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.44997 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.43873 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.44508 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.0879 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.01338 | 67 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.46082 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.26963 | 69 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.4271 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.44828 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.55538 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.10622 | 76 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.37543 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.46565 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.43382 | 71 |